Scarica l'app Stockscreener
48.02
0.04%
0.02
Dopo l'orario di chiusura:
48.02
Precedente Chiudi:
$48.00
Aprire:
$47.6
Volume 24 ore:
933.09K
Relative Volume:
1.54
Capitalizzazione di mercato:
$2.27B
Reddito:
$1.10B
Utile/perdita netta:
$186.50M
Rapporto P/E:
12.70
EPS:
3.7817
Flusso di cassa netto:
$267.19M
1 W Prestazione:
+3.40%
1M Prestazione:
-18.53%
6M Prestazione:
-19.40%
1 anno Prestazione:
-44.00%
Intervallo 1D:
$47.49
$48.59
Intervallo di 1 settimana:
$45.71
$48.59
Portata 52W:
$42.62
$87.12
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Nome
Prestige Consumer Healthcare Inc
Settore
Telefono
(914) 524-6800
Indirizzo
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
48.02 | 2.27B | 1.10B | 186.50M | 267.19M | 3.7817 |
TAK
Takeda Pharmaceutical Co Adr
|
15.87 | 51.34B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.24 | 41.15B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.61 | 39.67B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
80.23 | 34.09B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
578.43 | 24.13B | 3.17B | 1.29B | 1.01B | 27.09 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-24 | Aggiornamento | Sidoti | Neutral → Buy |
| 2024-12-09 | Downgrade | Sidoti | Buy → Neutral |
| 2024-06-21 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2022-11-17 | Iniziato | Canaccord Genuity | Buy |
| 2022-05-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-05-09 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-08-07 | Downgrade | DA Davidson | Buy → Neutral |
| 2020-06-29 | Aggiornamento | Sidoti | Neutral → Buy |
| 2020-04-14 | Downgrade | Jefferies | Buy → Hold |
| 2020-04-07 | Ripresa | Sidoti | Neutral |
| 2020-03-26 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-03-24 | Iniziato | Oppenheimer | Perform |
| 2020-03-19 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2019-01-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2017-12-04 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2017-06-02 | Aggiornamento | Jefferies | Underperform → Hold |
| 2017-05-22 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2016-12-27 | Reiterato | B. Riley & Co. | Buy |
| 2016-11-17 | Iniziato | Gabelli & Co | Buy |
| 2016-08-12 | Aggiornamento | Sidoti | Neutral → Buy |
| 2016-03-08 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2016-02-05 | Iniziato | Piper Jaffray | Overweight |
| 2015-11-30 | Downgrade | Jefferies | Hold → Underperform |
| 2014-04-28 | Reiterato | B. Riley & Co. | Buy |
| 2014-04-28 | Reiterato | Oppenheimer | Outperform |
| 2013-07-09 | Iniziato | B. Riley & Co. | Buy |
Mostra tutto
Prestige Consumer Healthcare Inc Borsa (PBH) Ultime notizie
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Prestige Consumer Healthcare Inc. (PBH) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Trading Systems Reacting to (PBH) Volatility - Stock Traders Daily
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: A 39% Upside Potential Amidst Strong Analyst Ratings - DirectorsTalk Interviews
Why Is Prestige Consumer Healthcare Stock Trending - Kalkine Media
PBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Encourages Prestige Consumer Healthcare Inc. (PBH) Investors to Inquire about Securities Investigation - ACCESS Newswire
Kinetics Spin-Off and Corporate Restructuring Fund's Prestige Consumer Healthcare Inc(PBH) Holding History - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages Prestige Consumer H - The National Law Review
Prestige Consumer Healthcare, Inc. (PBH) Securities Fraud InvestigationLevi & Korsinsky - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc.PBH - PR Newswire
Levi & Korsinsky Announces Investigation of Securities Claims Against Prestige Consumer Healthcare (PBH) - GlobeNewswire
Prestige Consumer Healthcare Inc. (PBH) Q4 2026 Earnings Call Transcript Summary - 富途牛牛
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Prestige Consumer Healthcare (PBH) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
PBH Investor Alert: Levi & Korsinsky Investigates Prestige Consumer Healthcare (PBH) for Potential Securities Fraud - marketscreener.com
INVESTOR ALERT: Investigation of Prestige Consumer Healthcare Inc. (PBH) announced by Holzer & Holzer, LLC - GlobeNewswire
Prestige Consumer Healthcare (PBH) Valuation After Missed Q4 Targets And Delayed LaCorium Deal Disclosure - Sahm
PBH SHAREHOLDER INVESTIGATION: SueWallSt Investigates Prestige Consumer Healthcare for Possible Securities Law Violations - PR Newswire
Prestige Consumer Healthcare (PBH): Investor Outlook Reveals 48.88% Potential Upside - DirectorsTalk Interviews
Prestige Consumer Healthcare Q4 earnings call highlights - MSN
Prestige Consumer Healthcare Inc. (NYSE:PBH) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Prestige Consumer Healthcare Inc. Just Missed EPS By 8.9%: Here's What Analysts Think Will Happen Next - 富途牛牛
Prestige Consumer Healthcare: Better Valuation, But Too Much Uncertainty To Buy - Seeking Alpha
Bessemer Group Inc. Acquires 32,331 Shares of Prestige Consumer Healthcare Inc. $PBH - MarketBeat
How InvestingPro’s Fair Value spotted Prestige Healthcare’s 46% drop By Investing.com - Investing.com
Prestige Consumer Healthcare (PBH) Is Down 11.0% After Earnings Miss And Surprise LaCorium Deal DisclosureWhat's Changed - Sahm
PBH Maintains Buy Rating, Price Target Lowered to $72 by Canacco - GuruFocus
Prestige Consumer Healthcare Balances Setbacks With Growth Plan - The Globe and Mail
Securities Fraud Investigation Into Prestige Consumer Healthcare (PBH) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Business Wire
Prestige Consumer Healthcare, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Prestige Consumer Healthcare (PBH) - Morningstar
Investigation launched over Prestige Consumer Healthcare's missed financial targets and undisclosed acquisition. - Pluang
Prestige Consumer Healthcare Inc. Just Missed EarningsBut Analysts Have Updated Their Models - Yahoo Finance
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q4 2026 Earnings Call Transcript - Insider Monkey
Prestige Consumer Healthcare Hits Day Low of $42.66 Amid Price Pressure - Markets Mojo
Prestige Consumer Healthcare Hits New 52-Week Low at $42.66 - Markets Mojo
Prestige Brands stock price target cut to $72 by Canaccord on sales miss - Investing.com Australia
Prestige Consumer Healthcare Inc. $PBH Shares Purchased by Leeward Investments LLC MA - MarketBeat
Oppenheimer downgrades Prestige Consumer Healthcare (PBH) - MSN
Prestige Consumer Healthcare Q4 Earnings Call Highlights - sharewise.com
Prestige Consumer Healthcare Inc. Overview: Major Brands, Competitive Strengths, and Growth Strategy in OTC Health Products - Minichart
PBH News | PRESTIGE CONSUMER HEALTHCARE (NYSE:PBH) - ChartMill
Prestige Consumer Healthcare Inc (PBH) Q4 2026 Earnings Call Hig - GuruFocus
Prestige Consumer Shares Slide on Weak Outlook, 4Q Underperformance - Moomoo
Prestige Consumer (PBH) Experiences Significant Decline - GuruFocus
How Prestige Consumer Healthcare Inc. (PBH) Affects Rotational Strategy Timing - Stock Traders Daily
Prestige Consumer Healthcare Inc (PBH) Shares Fall 11.3% -- What GF Score of 67 Tells Investors - GuruFocus
Prestige Consumer Healthcare forecasts $1.1B-$1.12B fiscal 2027 revenue with Clear Eyes growth weighted to the back half - MSN
Prestige Consumer (PBH) Downgraded by Oppenheimer Following Disa - GuruFocus
Prestige Consumer Hlthcr 4Q EPS $1.13 >PBH - Moomoo
Prestige Consumer Healthcare Inc. FY 2026: Revenue $1.09B, EPS $3.91— 10-K Summary - TradingView
OTC brand leader Prestige Consumer (PBH) outlines growth strategy and risks - Stock Titan
Prestige Consumer (PBH) CFO logs tax-related share withholding adjustment - Stock Titan
Prestige Consumer Healthcare Inc Azioni (PBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.02%
5.78%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):